ACON
NASDAQ
$2.63
Aclarion Inc (ACON)
Aclarion Inc (ACON) is a pioneering healthcare technology firm dedicated to advancing non-invasive diagnostic solutions for musculoskeletal conditions through cutting-edge imaging and data analytics. By harnessing the power of machine learning, Aclarion empowers healthcare providers with actionable insights that not only improve clinical outcomes but also optimize treatment pathways and reduce costs. Positioned at the forefront of the digital health revolution, the company is well-equipped to meet the rising demand for effective diagnostics, thereby significantly enhancing patient management and care standards in a dynamic healthcare landscape. Aclarion's commitment to improving patient care underscores its vital role in the future of healthcare delivery.
Sector:
Healthcare
Industry:
Health Information Services
Target: $7.50 (+185.17%)
Market Cap
$6.50M
P/B Ratio
0.33
Price Chart
Valuation
Market Cap$6.50M
P/S83.47
P/B0.33
Profitability
Total Revenue (TTM)$78K
Gross Profit (TTM)$15K
EBITDA-$8.31M
Operating Margin-14129%
EPS-$9.06
Growth & Risk
Sharpe Ratio-0.68